NCT03736018

Brief Summary

A large number of patients with symptomatic ischaemic heart disease undergo coronary artery bypass grafting (CABG) to alleviate their symptoms and improve prognosis. Given the progressive nature of coronary disease, bypass grafts can narrow or block over time, leading to chest pain and the need for further invasive coronary angiography. Invasive coronary procedures in patients with bypass grafts can be more complicated due to the variation in bypass graft ostia. This can lead to longer procedure times, with higher doses of contrast and radiation and more discomfort for the patient. The aim of this study is to see if the use of computed tomography cardiac angiography (CTCA) in patients with previous bypass grafts prior to invasive coronary angiography will help make their procedure safer and quicker.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
688

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 8, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

November 15, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

3.8 years

First QC Date

November 5, 2018

Last Update Submit

December 13, 2022

Conditions

Keywords

Coronary Artery Bypass GraftsComputed Tomography Cardiac AngiographyInvasive Coronary Angiogram

Outcome Measures

Primary Outcomes (3)

  • Procedural duration

    Length of invasive coronary angiogram

    Interval between administration of local anaesthesia for obtaining vascular access and removal of the last catheter

  • Incidence of Contrast Induced Nephropathy

    Defined by Kidney Disease: Improving Global outcomes (KDIGO) criteria

    48-72hours

  • Patient satisfaction

    Patient satisfaction measured by validated questionnaire

    4-6hours

Secondary Outcomes (8)

  • Contrast amount

    From time of arterial sheath insertion to removal of arterial catheters

  • Radiation exposure

    From time of arterial sheath insertion to removal of arterial catheters

  • Angiography related complications

    4-6hours

  • Radial access rate

    From time of randomisation to end of invasive coronary angiogram procedure

  • Catheters used

    From time of arterial sheath insertion to removal of arterial catheters

  • +3 more secondary outcomes

Study Arms (2)

CTCA + ICA

ACTIVE COMPARATOR

Computed Tomography Cardiac Angiography (CTCA) performed prior to invasive coronary angiogram (ICA).

Diagnostic Test: CTCA

ICA only

NO INTERVENTION

Invasive coronary angiogram (ICA) performed only.

Interventions

CTCADIAGNOSTIC_TEST

Computed Tomography Cardiac angiography (CTCA) performed prior to invasive coronary angiogram (ICA).

Also known as: Computed Tomography Cardiac angiography
CTCA + ICA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing invasive coronary angiogram +/- percutaneous coronary Intervention
  • Previous Coronary Artery Bypass Grafting (CABG)
  • Aged ≥18
  • Patients able and willing to give their written informed consent.

You may not qualify if:

  • Subjects presenting with ST elevation myocardial infarction, cardiogenic shock (systolic blood pressure \<80 mmHg for \>30 minutes, or requiring inotropes or emergency intra aortic balloon pump for hypotension treatment) or cardiopulmonary resuscitation.
  • Subjects with eGFR \<20ml/min or on renal replacement therapy.
  • Current life-threatening condition other than vascular disease that may prevent a subject completing the study.
  • Clinical instability including cardiogenic shock, hypotension (low blood pressure-systolic blood pressure less than 90 mmHg), sustained ventricular or atrial arrhythmia requiring intravenous medications.
  • Inability to tolerate beta-blockers, including those with chronic obstructive pulmonary disease or asthma, complete heart block, second-degree atrioventricular block
  • Known contrast dye allergy.
  • Pregnancy or unknown pregnancy status.
  • Patients considered unsuitable to participate by the research team (e.g., due to medical reasons, laboratory abnormalities, or subject's unwillingness to comply with all study related procedures).
  • Inability or refusal to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barts Health NHS Trust

London, United Kingdom

Location

Related Publications (4)

  • Kelham M, Beirne AM, Rathod KS, Andiapen M, Wynne L, Learoyd AE, Forooghi N, Ramaseshan R, Moon JC, Davies C, Bourantas CV, Baumbach A, Manisty C, Wragg A, Ahluwalia A, Pugliese F, Mathur A, Jones DA. CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilization, and Cardiac Events at 3 Years From the BYPASS-CTCA Trial. Circ Cardiovasc Interv. 2024 Dec;17(12):e014142. doi: 10.1161/CIRCINTERVENTIONS.124.014142. Epub 2024 Nov 25.

  • Kelham M, Beirne AM, Rathod KS, Andiapen M, Wynne L, Ramaseshan R, Learoyd AE, Forooghi N, Moon JC, Davies C, Bourantas CV, Baumbach A, Manisty C, Wragg A, Ahluwalia A, Pugliese F, Mathur A, Jones DA; BYPASS-CTCA Trial Investigators. The effect of CTCA guided selective invasive graft assessment on coronary angiographic parameters and outcomes: Insights from the BYPASS-CTCA trial. J Cardiovasc Comput Tomogr. 2024 May-Jun;18(3):291-296. doi: 10.1016/j.jcct.2024.03.004. Epub 2024 Mar 11.

  • Jones DA, Beirne AM, Kelham M, Rathod KS, Andiapen M, Wynne L, Godec T, Forooghi N, Ramaseshan R, Moon JC, Davies C, Bourantas CV, Baumbach A, Manisty C, Wragg A, Ahluwalia A, Pugliese F, Mathur A; BYPASS-CTCA Trial Committees and Investigators. Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial. Circulation. 2023 Oct 31;148(18):1371-1380. doi: 10.1161/CIRCULATIONAHA.123.064465. Epub 2023 Sep 29.

  • Beirne AM, Rathod KS, Castle E, Andiapen M, Richards A, Bellin A, Hammond V, Godec T, Moon JC, Davies C, Bourantas CV, Wragg A, Ahluwalia A, Pugliese F, Mathur A, Jones DA. The BYPASS-CTCA Study: the value of Computed Tomography Cardiac Angiography (CTCA) in improving patient-related outcomes in patients with previous bypass operation undergoing invasive coronary angiography: Study Protocol of a Randomised Controlled Trial. Ann Transl Med. 2021 Sep;9(17):1395. doi: 10.21037/atm-21-1455.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Daniel Jones, MRCP, PhD

    Queen Mary University of London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2018

First Posted

November 8, 2018

Study Start

November 15, 2018

Primary Completion

August 30, 2022

Study Completion

September 30, 2023

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

Trial protocol to be published

Shared Documents
STUDY PROTOCOL
Time Frame
Late 2018
Access Criteria
Freely available via journal

Locations